Article
SF3B1 mutant myelodysplastic syndrome: Recent advances.
Advances in biological regulation - 1 Jan 2021
Pellagatti Andrea, Boultwood Jacqueline
Abstract excerpt
The myelodysplastic syndromes (MDS) are common myeloid malignancies. Mutations in genes encoding different components of the spliceosome occur in more than half of all MDS patients. SF3B1 is the most frequently mutated splicing factor gene in MDS, and there is a strong association between SF3B1 mutations and the presence of ring sideroblasts in the bone marrow of MDS patients. It has been recently proposed that...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
